Drug intelligence / Profile preview

lapachone

Development stage
Phase 2
Lead developer
Merck
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Lapachone (also known as beta-lapachone or β-lapachone) is a small molecule ortho-naphthoquinone originally isolated from the bark of the Lapacho tree in South America. It has been investigated primarily as an anticancer agent, with additional reported antifungal, antiviral, and antitrypanosomal properties. Its mechanism of action is highly specific to cancer cells that overexpress NAD(P)H:quinone oxidoreductase 1 (NQO1), an enzyme found at elevated levels in many solid tumors such as those of the pancreas, lung, breast, prostate, and head and neck. In NQO1-positive tumor cells, lapachone undergoes a futile redox cycle catalyzed by NQO1 that generates high levels of reactive oxygen species (ROS), leading to DNA damage and hyperactivation of poly(ADP-ribose) polymerase (PARP). This results in rapid depletion of NAD+ and ATP within cancer cells—causing metabolic catastrophe and cell death—while sparing normal tissues with low NQO1 expression. Lapachone has also shown potential as a radiosensitizer for enhancing radiation therapy efficacy[2][3][5][9].

Other names
beta-lapachoneβ-lapachone
02

Targets

NQO1

Beyond the preview

Go deeper on lapachone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lapachone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call